Viking Therapeutics Inc (NAS:VKTX)
$ 42.35 0.03 (0.07%) Market Cap: 4.72 Bil Enterprise Value: 3.79 Bil PE Ratio: 0 PB Ratio: 5.18 GF Score: 37/100

Q3 2020 Viking Therapeutics Inc Earnings Call Transcript

Oct 28, 2020 / 08:30PM GMT
Release Date Price: $5.3 (-4.85%)
Operator

Welcome to the Viking Therapeutics 2020 Third Quarter Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, October 28, 2020. I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie.

Stephanie Diaz
Vida Strategic Partners Inc. - President & CEO

Hello and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Senior Vice President of Finance.

Before we begin, I'd like to caution that comments made during this conference call today, October 28, 2020, will contain forward-looking statements within the meaning of the Securities Act of 1933, concerning the current beliefs of the company, which involve a number of assumptions, risks and uncertainties. Actual results could differ from these statements, and the company undertakes no obligation to revise or update any statement made today. I encourage you to review all of the company's filings with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot